Trials / Conditions / Recurrent Malignant Peripheral Nerve Sheath Tumor
Recurrent Malignant Peripheral Nerve Sheath Tumor
5 registered clinical trials studyying Recurrent Malignant Peripheral Nerve Sheath Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tum NCT04530487 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot NCT02700230 | Mayo Clinic | Phase 1 |
| Terminated | Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma NCT02601209 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma NCT02452554 | Children's Oncology Group | Phase 2 |
| Completed | Alisertib in Treating Patients With Advanced or Metastatic Sarcoma NCT01653028 | National Cancer Institute (NCI) | Phase 2 |